Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2010.195 | Prevalence of undiagnosed COPD and their systemic inflammation among patients with pre-existing cardiovascular disease | Dr. Ko Fanny Wai San |
| 2023.330 | Genetic association with various severities, phenotypes and endotypes of asthma | Dr. KO Fanny Wai San |
| 2020.518 | Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma |
Dr. KO Fanny Wai San 古惠珊醫生 |
| 2022.679 | Predicting adverse outcomes using machine learning of COPD patients in Hong Kong | Dr. KO Fanny Wai San |
| 2022.167 | Telemedicine for out-patient management of adult asthma patients, effect on quality of life and asthma control, a randomised control trial. |
Dr. KO Fanny Wai San 古惠珊 |
| 2020.507 | To assess the management of patients on Global Initiative of Asthma (GINA) step 4 and 5 treatment in Hong Kong |
Dr. KO Fanny Wai San 古惠珊醫生 |
| 2024.655 | COPD Phenotypes, Endotypes and Treatable Traits in Hong Kong | Dr. KO Fanny Wai San |
| 2025.641 | Developing a Digital Self-Guided Breathlessness Supportive Intervention for Patients with Chronic Breathlessness due to Cancer and Chronic Respiratory Diseases | Dr. Ko Fanny Wai San |
| 2025.228 | Use of biologics for severe asthma in Hong Kong | Dr. KO Fanny Wai San |
| 2025.669 | International Severe Asthma Registry | Dr. Ko Fanny Wai San |
| 2025.584 | Local epidemiology, prevalence and clinical outcomes of subjects with preserved ratio impaired spirometry | Dr. KO Fanny Wai San |
| 2025.798 | A prospective study of cardiovascular risk of patients admitted for acute exacerbation of COPD | Dr. Ko Fanny Wai San |
| 2025.445 | A Prospective Study on Asthma and Chronic Obstructive Pulmonary Disease (COPD) Phenotypes, Endotypes and Treatable Traits for the Planning of Further Intervention Studies | Dr. KO Fanny Wai San |
| 2025.429 | Viral infections and subsequent development of acute respiratory distress syndrome and interstitial lung disease | Dr. KO Fanny Wai San |
| 2018.042 | Clinical phenotype of Chronic Obstructive Pulmonary Disease (COPD): retrospective medical records review | Dr. KO Fanny Wai San |
| 2019.395 | Level of FeNO in Chinese Asthma Patients |
Dr. KO Fanny Wai San 古惠珊 |
| 2014.081 | Disease impact of COPD on bone health, physical and cognitive function | Dr. KO Fanny Wai San |
| 2026.528 | Clinical characteristics for airway patients in Hong Kong – A territory wide study | Dr. KO Fanny Wai San |
| 2026.503 | Burden of adult respiratory tract infections and the risk factors for adverse outcomes – A territory wide cohort study | Dr. KO Fanny Wai San |
| 2015.400 | Screening for cognitive impairment of the elderly in-patients of an acute general hospital. |
Dr. KO Flora 高淑蘭 |
| 2026.605 | Chinese University- Alzheimer's Disease with Vascular and other Co-pathology: Towards Actionable Neuro- Cognitive-Omic Evaluations | Prof. Ko Ho |
| 2022.120 | Tropism and pathogenesis of influenza virus and coronavirus in human brain explant culture |
Dr. KO Ho 高浩 |
| 2019.155 | Surface-enhanced Raman spectroscopy of cerebrospinal fluid for diagnosis of neurodegenerative diseases: a proof-of-concept study |
Prof. KO Ho 高浩 |
| 2021.306 | The effects of evidence-based yoga protocol on physical and psychological outcomes among community-dwelling older adults. Randomized control trial. |
Ms. KO Ka Yan 高嘉恩 |
| 2008.406 | Development of an Outcome Measure for Hong Kong chinese Women with Breast Cancer-related Lymphoedema | Ms. KO Pik-ha, Betty |
| 2013.329 | Development of an interview schedule for the assessment of mental capacity to make decisions in signing an enduring power of attorney in Chinese older persons | Dr. KO SHUK FUN |
| 2019.499 | Establishing evidence to speech and language intervention of Cantonese Speakers with Primary Progressive Aphasia (PPA). | Dr. KO Shuk Fun |
| 2019.461 | Development, Validation and Psychometric Evaluation of the Chinese version of the Frontotemporal Dementia Rating Scale (C-FTD-FRS) | Dr. KO Shuk Fun |
| 2015.016 | The effects of music interventions on anxiety and pain for Chinese adult patients undergoing colonoscopy: a pilot study | Miss Ko Shuk Yee |
| 2018.477 | Evaluation of pulmonary rehabilitation program for patients with chronic respiratory diseases other than COPD |
Mr. KO Wai Nam 高蔚南 |
| 2015.164 | Multiplex Molecular Detection of Respiratory Pathogens of adult patients admitted to hospital for exacerbation of asthma and chronic obstructive pulmonary disease and their clinical outcomes. | Dr. KO Wai San |
| 2015.544 | The effects of Activskin on deep partial thickness burns: a randomized control trial | Dr. KO Wai Shan |
| 2016.075 | Evaluation of the efficacy and safety of combined application of CGPASTE and CuraVAC® on chronic wound |
Dr. KO Wai Shan 高慧珊 |
| 2016.455 | The effects of Activskin on chronic ulcers: a pilot trial | Dr. KO Wai Shan |
| 2026.170 | The clinical efficacy of micro-punch excision combined with adjuvant therapies for keloids and hypertrophic scars | Dr. KO Wai Shan |
| 2025.061 | Pilot Observational Study of BioRNA Treatment of Keloid and hypertrophic burns scars | Dr. KO Wai Shan |
| 2007.429 | A Study of the Infectious Etiologies of Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease | Dr Ko Wai-san Fanny |
| 2008.442 | A Comprehensive Care Programme for Patients with Chronic Obstructive Pulmonary Disease | Dr. Ko Wai-san Fanny |
| 2014.209 | Anti-viral and anti-inflammatory role of Vitamin D in airway epithelia infected with human rhinovirus species C | Prof Ko Wing hung |
| 2017.086 | Role of sphingosine 1-phosphate signaling in regulating electrolyte transport and P2Y receptor-mediated pro-inflammatory cellular response in human airway epithelia |
Prof. KO Wing hung 高永雄教授 |
| 2016.132 | Role of sphingosine 1-phosphate signaling in regulating electrolyte transport and P2Y receptor-mediated pro-inflammatory cellular response in human airway epithelia |
Prof. KO Wing Hung 高永雄教授 |
| 2017.243 | Association between branched-chain amino acids and renal function in Chinese type 2 diabetes patients with MTOR genetic variants | Prof. KONG Alice Pik Shan |
| 2016.641 | A Pragmatic Clinical Trial to Address the Knowledge Gaps and Unmet Needs in the Management of Patients with Type 2 Diabetes and Chronic Liver Disease |
Prof. KONG Alice Pik Shan 江碧珊醫生 |
| 2017.201 | Relationship between Environmental Pollutants and Depression in Patients with Type 2 Diabetes |
Prof. KONG Alice Pik Shan 江碧珊醫生 |
| 2015.406 | A multi-center, double blind, randomized, placebo controlled study of Testogel® (testosterone gel 50mg/5g) in the treatment of male hypogonadism | Prof. KONG Alice Pik Shan |
| 2016.213 | Early detection of liver cancer in type 2 diabetes using serum microRNA |
Prof. KONG Alice Pik Shan 江碧珊 |
| 2010.516 | A randomized controlled trial to investigate the impact of sleep education program on glycemic control in Hong Kong Chinese type 2 diabetic patients. | Prof. KONG Alice Pik Shan |
| 2009.210 | TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control | Dr. Kong Alice Pik Shan |
| 2021.575 | The effect of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on progression of nonalcoholic fatty liver disease (NAFLD) in Hong Kong Chinese with type 2 diabetes (T2D) | Prof. KONG Alice Pik Shan |
| 2023.087 | Using inflammatory markers and microRNA to identify obese individuals at risk of nonalcoholic steatohepatitis | Prof. KONG Alice Pik Shan |
Page 117 of 289.